Literature DB >> 19683004

Structural basis of conserved cysteine in the fibroblast growth factor family: evidence for a vestigial half-cystine.

Jihun Lee1, Michael Blaber.   

Abstract

The 22 members of the mouse/human fibroblast growth factor (FGF) family of proteins contain a conserved cysteine residue at position 83 (numbering scheme of the 140-residue form of FGF-1). Sequence and structure information suggests that this position is a free cysteine in 16 members and participates as a half-cystine in at least 3 (and perhaps as many as 6) other members. While a structural role as a half-cystine provides a stability basis for possible selective pressure, it is less clear why this residue is conserved as a free cysteine (although free buried thiols can limit protein functional half-life). To probe the structural role of the free cysteine at position 83 in FGF-1, we constructed Ala, Ser, Thr, Val, and Ile mutations and determined their effects on structure and stability. These results show that position 83 in FGF-1 is thermodynamically optimized to accept a free cysteine. A second cysteine mutation was introduced into wild-type FGF-1 at adjacent position Ala66, which is known to participate as a half-cystine with position 83 in FGF-8, FGF-19, and FGF-23. Results show that, unlike position 83, a free cysteine at position 66 destabilizes FGF-1; however, upon oxidation, a near-optimal disulfide bond is formed between Cys66 and Cys83, resulting in approximately 14 kJ/mol of increased thermostability. Thus, while the conserved free cysteine at position 83 in the majority of the FGF proteins may have a principal role in limiting functional half-life, evidence suggests that it is a vestigial half-cystine.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19683004     DOI: 10.1016/j.jmb.2009.08.007

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  13 in total

1.  An empirical phase diagram approach to investigate conformational stability of "second-generation" functional mutants of acidic fibroblast growth factor-1.

Authors:  Mohammad A Alsenaidy; Tingting Wang; Jae Hyun Kim; Sangeeta B Joshi; Jihun Lee; Michael Blaber; David B Volkin; C Russell Middaugh
Journal:  Protein Sci       Date:  2012-02-06       Impact factor: 6.725

2.  Experimental support for the evolution of symmetric protein architecture from a simple peptide motif.

Authors:  Jihun Lee; Michael Blaber
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-20       Impact factor: 11.205

3.  Impact of cysteine variants on the structure, activity, and stability of recombinant human α-galactosidase A.

Authors:  Huawei Qiu; Denise M Honey; Jonathan S Kingsbury; Anna Park; Ekaterina Boudanova; Ronnie R Wei; Clark Q Pan; Tim Edmunds
Journal:  Protein Sci       Date:  2015-07-14       Impact factor: 6.725

4.  Engineering a Cysteine-Free Form of Human Fibroblast Growth Factor-1 for "Second Generation" Therapeutic Application.

Authors:  Xue Xia; Ozan S Kumru; Sachiko I Blaber; C Russell Middaugh; Ling Li; David M Ornitz; Mason A Sutherland; Connie A Tenorio; Michael Blaber
Journal:  J Pharm Sci       Date:  2016-04       Impact factor: 3.534

5.  Variable expressivity of FGF3 mutations associated with deafness and LAMM syndrome.

Authors:  Saima Riazuddin; Zubair M Ahmed; Rashmi S Hegde; Shaheen N Khan; Idrees Nasir; Uzma Shaukat; Sheikh Riazuddin; John A Butman; Andrew J Griffith; Thomas B Friedman; Byung Yoon Choi
Journal:  BMC Med Genet       Date:  2011-02-09       Impact factor: 2.103

6.  Creation of Cross-Linked Crystals With Intermolecular Disulfide Bonds Connecting Symmetry-Related Molecules Allows Retention of Tertiary Structure in Different Solvent Conditions.

Authors:  Takeshi Hiromoto; Teikichi Ikura; Eijiro Honjo; Michael Blaber; Ryota Kuroki; Taro Tamada
Journal:  Front Mol Biosci       Date:  2022-06-08

7.  X-ray structure and biophysical properties of rabbit fibroblast growth factor 1.

Authors:  Jihun Lee; Sachiko I Blaber; Andre Irsigler; Eric Aspinwall; Michael Blaber
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2009-10-30

8.  Dynamic folding modulation generates FGF21 variant against diabetes.

Authors:  Lei Zhu; Hongxin Zhao; Juanjuan Liu; Hao Cai; Bo Wu; Zhijun Liu; Shu Zhou; Qingsong Liu; Xiaokun Li; Bin Bao; Jian Liu; Han Dai; Junfeng Wang
Journal:  EMBO Rep       Date:  2020-12-09       Impact factor: 9.071

9.  The Effect of Covalently Immobilized FGF-2 on Biphasic Calcium Phosphate Bone Substitute on Enhanced Biological Compatibility and Activity.

Authors:  Kyung-Suk Moon; Eun-Joo Choi; Seunghan Oh; Sungtae Kim
Journal:  Biomed Res Int       Date:  2015-09-07       Impact factor: 3.411

Review 10.  Protein comparability assessments and potential applicability of high throughput biophysical methods and data visualization tools to compare physical stability profiles.

Authors:  Mohammad A Alsenaidy; Nishant K Jain; Jae H Kim; C Russell Middaugh; David B Volkin
Journal:  Front Pharmacol       Date:  2014-03-12       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.